3. Harper C. Diagnostic and statistical manual of mental disorders. In: Taylor P, Corteen K, Morley S, editors. A companion to criminal justice, mental health and risk. Bristol (UK): The Policy Press, 2014.
4. Siu MT, Weksberg R. Epigenetics of autism spectrum disorder. Adv Exp Med Biol 2017;978:63–90.
11. Ou J, Shen Y, Li Y, Xun G, Liu H, He Y, et al. Prenatal environment and perinatal factors associated with autism spectrum disorder. Glob Clin Transl Res 2019;1:100–8.
12. Lyall K, Pauls DL, Spiegelman D, Ascherio A, Santangelo SL. Pregnancy complications and obstetric suboptimality in association with autism spectrum disorders in children of the Nurses' Health Study II. Autism Res 2012;5:21–30.
13. Bitar T, Gerges P, Kassab MC, Hallit S, Mattar H, Soufia M, et al. Factors associated with Autism Spectrum Disorder: a case-control study in the Lebanese population. Epidemiol Biostat Public Health 2020;17:e13218.
15. Hamadé A, Salameh P, Medlej-Hashim M, Hajj-Moussa E, SaadallahZeidan N, Rizk F. Autism in children and correlates in Lebanon: a pilot case-control study. J Res Health Sci 2013;13:119–24.
16. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000;283:2008–12.
17. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [Internet]. Ottawa (ON): Ottawa Hospital Research Institute; c2021 [cited 2021 Dec 10]. Available from:
http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
20. Stein D, Weizman A, Ring A, Barak Y. Obstetric complications in individuals diagnosed with autism and in healthy controls. Compr Psychiatry 2006;47:69–75.
23. Auf KAM, Al-Nagar E-SM, Al-Gendy RAR, Abd El-Raouf ER. Screening of autism spectrum disorder by using Gilliam Autism Rating Scale in a sample of Egyptian children attending Bab Al Sha’reya University Hospital. Al-Azhar J Ped 2020;23:1259–73.
24. Vui LT, Quynh CTT, Quynh NT, Huong NM, Thuy NTH, Ha BTT, et al. Prevalence of autism spectrum disorders and their relation to selected factors among children aged 18-30 months in Hoa Binh province, 2017. J Health Dev Stud 2019;3:6–17.
28. El-Tallawy HN, Farghaly WM, Shehata GA, Rageh TA, Metwally NA, Badry R, et al. Cerebral palsy in Al-Quseir City, Egypt: prevalence, subtypes, and risk factors. Neuropsychiatr Dis Treat 2014;10:1267–72.
33. Ashoor G, Maiz N, Rotas M, Jawdat F, Nicolaides KH. Maternal thyroid function at 11 to 13 weeks of gestation and subsequent fetal death. Thyroid 2010;20:989–93.
35. Rand JH, Wu XX, Andree HA, Lockwood CJ, Guller S, Scher J, et al. Pregnancy loss in the antiphospholipid-antibody syndrome—a possible thrombogenic mechanism. N Engl J Med 1997;337:154–60.
38. Quenby S, Kalumbi C, Bates M, Farquharson R, Vince G. Prednisolone reduces preconceptual endometrial natural killer cells in women with recurrent miscarriage. Fertil Steril 2005;84:980–4.
39. Ross G, Sammaritano L, Nass R, Lockshin M. Effects of mothers' autoimmune disease during pregnancy on learning disabilities and hand preference in their children. Arch Pediatr Adolesc Med 2003;157:397–402.
42. Jiang HY, Xu LL, Shao L, Xia RM, Yu ZH, Ling ZX, et al. Maternal infection during pregnancy and risk of autism spectrum disorders: A systematic review and meta-analysis. Brain Behav Immun 2016;58:165–72.
46. Wan H, Zhang C, Li H, Luan S, Liu C. Association of maternal diabetes with autism spectrum disorders in offspring: A systemic review and metaanalysis. Medicine (Baltimore) 2018;97:e9438.
47. Fusar-Poli P, Radua J. Ten simple rules for conducting umbrella reviews. Evid Based Ment Health 2018;21:95–100.